LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

(R)-norfluoxetine in method for occupying serotonin IC receptors

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...

(R,S)-1-(3-Hydroxy-4-methoxybenzoyl)-3-hydroxy-2-pyrrolidinone i

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(R/S) rifamycin derivatives, their preparations and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

(RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) aceti

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(S)-(+)-hydroxychloroquine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

(S)-(-)-1-(4-fluoroisoquinolin-5-Yl)Sulfonyl-2-methyl-1,4-ho...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(S)-1-[(10-chloro-6,7-dih ydro-4-oxo-3-phenyl-4H-benzo[a]quino-l

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

(S)-2,3-dihydropolyprenyl, monophosphate, and agents for inhibit

Drug – bio-affecting and body treating compositions – Dentifrices – Ammonia – amine – or derivative thereof

(S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyri

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(S)-4-AMINO-5-CHLORO-2-METHOXY-N-[1-[1-(2-TETRAHYD...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(S)-7-(3-amino-1-pyrrolidinyl)-1-cyclop ropyl-6-fluoro-1,4-dihyd

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

(S)-emopamil for the treatment of migraine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

(S)-hydroxynefazodone antipsychotic therapy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

(S)-N.sup.6 -2-hydroxypropyladenosines

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

(S)-norfluoxetine in method of inhibiting serotonin uptake

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills

(S,R) formoterol methods and compositions

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

(Substituted 2-carboxyanilino)nicotinic acids as inhibitors of a